Quick Answer
Evolent Health, Inc. reported Total Revenue of $1.88 billion for fiscal year 2025.
Evolent Health, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.88B | -26.6% |
| 2024 | $2.55B | +30.1% |
| 2023 | $1.96B | +45.3% |
| 2022 | $1.35B | +48.9% |
| 2021 | $907.96M | -1.8% |
| 2020 | $924.64M | +34.6% |
| 2019 | $687.12M | +9.6% |
| 2018 | $627.06M | +44.2% |
| 2017 | $434.95M | +71.1% |
| 2016 | $254.19M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $479.53M | -22.8% | +7.9% |
| June 30, 2025 | $444.33M | -31.3% | -8.1% |
| March 31, 2025 | $483.65M | -24.4% | -22.2% |
| September 30, 2024 | $621.40M | +21.6% | -4.0% |
| June 30, 2024 | $647.14M | +37.9% | +1.2% |
| March 31, 2024 | $639.65M | +49.6% | +25.2% |
| September 30, 2023 | $511.01M | +44.9% | +8.9% |
| June 30, 2023 | $469.14M | +46.6% | +9.7% |
- Evolent Health, Inc. showed a decrease of -26.6% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, Evolent Health, Inc.’s total revenue has grown by 638.1% (from $254.19 million to $1.88 billion).
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: